OBJECTIVE: To evaluate the effectiveness of prophylactic abdominal aorta @entity432 in cases of placenta previa with abnormal placentation. METHODS: In a retrospective study, data were analyzed for @entity1 who had placenta previa with @entity8052 and underwent elective cesarean delivery (>34  weeks) with or without temporary @entity432 at a center in Zhengzhou, China, between October 2015 and September 2016. The primary clinical outcomes were operative time, estimated @entity190 , intraoperative blood transfusion volume, hemoglobin, hysterectomy, and hospitalization. RESULTS: Among 69 eligible @entity1 , 38 had @entity432 , and 31 had no @entity432 . Operative time, blood transfusion volume, change in hemoglobin, hysterectomy, and length of hospitalization did not differ. Although mean @entity190 did not differ, fewer @entity1 in the balloon group than the non-balloon group had an estimated @entity190 of more than 1000  mL (24 [63%] vs 28 [90%]; P=0.009). In terms of different placental types, the estimated @entity190 among @entity1 with @entity8052 was lower in the balloon group than in the non-balloon group (P<0.001 and P=0.01, respectively). CONCLUSION: Prophylactic @entity432 of the abdominal aorta reduced @entity548 after cesarean delivery for @entity1 with abnormal placentation. This article is protected by copyright. All rights reserved.

Retrospective analysis of placenta previa with abnormal placentation with and without prophylactic use of abdominal aorta XXXX .

@entity1 :: ('9606', 'Species') :: ['women', 'patients'] @entity548 :: ('MESH:D006470', 'Disease') :: ['bleeding'] @entity190 :: ('MESH:D006473', 'Disease') :: ['blood loss'] @entity8052 :: ('MESH:D010921', 'Disease') :: ['placenta accreta and placenta increta', 'placenta accreta'] @entity432 :: ('MESH:D001157', 'Disease') :: ['balloon occlusion', 'temporary balloon occlusion', 'aortic balloon occlusion']
@entity432 :: (MESH:D001157,Disease) :: ['balloon occlusion']
